Producer

Merck Animal Health (MSD Animal Health)

MRKHQ US · New Jerseywebsite ↗

Merck Animal Health (Madison NJ; division of Merck & Co.; ~$5.5B revenue) manufactures AviPro brand avian influenza and Newcastle disease vaccines for commercial poultry. Products sold as MSD Animal Health outside North America. Merck Animal Health is the third-largest animal health company globally. De Soto KS biologics manufacturing site.

5

Inputs supplied

4

Goods downstream

4

Facilities

0

Stories

Where it shows up

Goods downstream

Essential goods that depend on something Merck Animal Health (MSD Animal Health) makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Poultry Vaccines & Biologics

    35%
  • Cattle & Livestock Vaccines

    30%
  • Companion Animal & Parasiticides

    22%
  • Aquaculture Vaccines

    13%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Did you know2023

    Merck Animal Health's RISMAVAC — the frozen CVI988/Rispens live virus vaccine for Marek's disease, stored below -150°C — is produced at the Boxmeer, Netherlands facility where the Rispens strain was originally developed in 1972. Merck the human pharmaceutical company also makes Varivax (varicella/chickenpox vaccine) and Zostavax (shingles vaccine) from the same family of herpesviruses in its human biologics divisions. Both a mandatory livestock vaccine and a standard childhood vaccine trace to the same company's herpesvirus manufacturing expertise — though produced by entirely separate divisions and regulatory frameworks.

    Merck Animal Health
  • Origin2023

    Merck Animal Health traces its origin to Sharp & Dohme's acquisition of the veterinary biologics company in the 1950s, which was absorbed when Merck & Sharp & Dohme merged in 1953. The animal health division grew from a small sideline into a ~$5.5 billion revenue business, driven by livestock intensification in the second half of the 20th century. The 2009 Merck-Schering-Plough merger added the MSD Animal Health brand and its Netherlands operations (including the Boxmeer facility where the Rispens Marek's vaccine strain was developed), making Merck one of the three dominant global poultry vaccine manufacturers.

    Merck Animal Health